Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at one-tenth of the original cost.

Mankind Pharma on Wednesday said it has launched a generic version of diabetes medication Empagliflozin in the country.      The company has launched Empagliflozin tablets under brand names Empaglyde, ...

The uptick in the Morepen Labs share came after the company announced that it has rolled out ‘Empamore.’ Empamore is used to ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed ...

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 ...

5.49 per tablet for the 10 mg variant and Rs. 9.9 per tablet for the 25 mg variant, making cheaper by more than 90%. The cost of empagliflozin was earlier priced at Rs. 58.7 per tablet for the 10 mg ...

Currently priced at Rs 60 per tablet, Empagliflozin’s generic versions will be available for as low as Rs 9-Rs 14 per tablet, significantly reducing costs for millions of patients, states the report.

By introducing Empagliflozin at INR 5.49 per tablet for the 10 mg variant and INR 9.90 per tablet for the 25 mg variant, we are ensuring that cost is no longer a barrier to access. The original ...

Empagliflozin improved clinical outcomes in patients with acute heart failure (AHF), regardless of blood pressure (BP) levels, with particularly strong benefits observed in those with diastolic BP ...